Ad is loading...
FAKDX
Price
$12.48
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
VIVIX
Price
$68.70
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

FAKDX vs VIVIX

Header iconFAKDX vs VIVIX Comparison
Open Charts FAKDX vs VIVIXBanner chart's image
Kempner Multi-Cap Deep Value Investor
Price$12.48
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
FAKDX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAKDX vs. VIVIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAKDX is a Buy and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. FAKDX (96.3M). VIVIX pays higher dividends than FAKDX: VIVIX (2.37) vs FAKDX (1.82). FAKDX was incepted earlier than VIVIX: FAKDX (16 years) vs VIVIX (26 years). FAKDX is a more actively managed with annual turnover of: 34.00 vs. VIVIX (10.00). FAKDX has a lower initial minimum investment than VIVIX: FAKDX (500) vs VIVIX (5000000). FAKDX (26.16) and VIVIX (25.54) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.79 vs. FAKDX (22.94).
FAKDXVIVIXFAKDX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years26 years-
Gain YTD19.48717.922109%
Front LoadN/AN/A-
Min. Initial Investment50050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets96.3M184B0%
Annual Yield % from dividends1.822.3777%
Returns for 1 year26.1625.54102%
Returns for 3 years2.4321.5711%
Returns for 5 years22.9450.7945%
Returns for 10 years26.78110.5024%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXR164.561.13
+0.69%
Extra Space Storage
PALT1.83N/A
N/A
Paltalk
AOMR9.80-0.06
-0.61%
Angel Oak Mortgage REIT
DLO9.89-0.31
-3.04%
DLocal Limited
GYRE13.12-0.72
-5.20%
Gyre Therapeutics